WHO ARE WE? SAPPIENS is a subsidiary of CXS Therapeutics, our bioinformatics platform dedicated to identifying and developing therapeutic molecules for diseases affecting the central nervous system. SAPPIENS was created following the identification of a new drug candidate for Parkinson's disease, and its objective is to carry out the pharmaceutical development of a ... Read more on the SAPPIENS HOMEPAGE